ARMO BioSciences Inc. (Nasdaq: ARMO) will be acquired by Eli Lilly (NYSE: LLY) for a premium of approximately $1.6 billion in cash. Shares of ARMO BioSciences rocketed $19.98 to close at $49.80 while Eli Lilly stock climbed $1.59 to close at $80.86.
Eli Lilly to buy ARMO BioSciences
May 10, 2018 at 17:09 PM EDT
